{
"info": {
"nct_id": "NCT04149691",
"official_title": "A Phase I, Open-label, Multicentre, Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies",
"inclusion_criteria": "* Patient or legal guardian, if permitted by local regulatory authorities, provides informed consent to participate in the study must be performed before any procedure's protocol related\n* age of ≥25 years old\n* Performance Score ≥70 in accordance with the Karnofsky Performance Score (KPS),\n* life expectancy period of at least 3 months on the screening day,\n* Have measurable disease according to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1)\n* subject (or his/her partner) of childbearing potential willingness to use acceptable forms of contraception\n* adequate blood, liver, renal and urine parameters\n* phosphate levels within normal range\n* HIV, HCV (hepatitis C virus) and HBV negative (hepatitis B virus),\n* adequate cardiac function\n\nInclusion Criteria Specific for parts:\n\nPart 1\n\n* Patients with histologically confirmed advanced gastric cancer, bladder cancer, squamous lung cancer or non-small cell lung cancer with squamous immunophenotype, cholangiocarcinoma, sarcoma or endometrial cancer, be refractory to prior therapies and without effective further treatment options.\n\nPart 2 and 3\n\n* Patients with histologically confirmed advanced gastric cancer, bladder cancer, squamous lung cancer or non-small cell lung cancer with squamous immunophenotype, be refractory to prior therapies and without effective further treatment options.\n* Subject's archival formalin-fixed paraffin-embedded (FFPE) tumour sample available for molecular alteration diagnostics, and/or a possibility to collect a new biopsy.\n* Present molecular alteration within FGFR 1, 2 or 3\nHealthy volunteers allowed\nMust have minimum age of 25 Years",
"exclusion_criteria": "* Any other current malignancy or malignancy diagnosed within the past five (5) years.\n* Active brain metastases or leptomeningeal metastases.\n* concurrent anticancer treatment within 28 days before the start of trial treatment; major surgery within 28 days before the start of trial treatment); use of blood transfusion within 7 days before the start of trial treatment,\n* prior therapy with an agent directed to another FGFR inhibitor,\n* pregnancy and/or breastfeeding,\n* phosphate levels above the upper limit of normal,\n* ectopic calcification/mineralization,\n* endocrine alteration related to calcium/phosphate homeostasis e.g. parathyroid disorders, history of parathyroidectomy,\n* concomitant therapies increasing calcium/phosphate serum levels,\n* inability to take oral medicines,\n* corneal disorder and/or keratopathy,\n* persisting toxicity related to prior therapy Grade > 1 CTCAE v5.0, except polyneuropathy and alopecia,\n* clinically significant (i.e., active) cardiovascular disease. History of abdominal fistula, bowel obstruction (Grade IV), gastrointestinal perforation, intra-abdominal abscess within 6 months of enrollment. Other significant diseases, which, in the opinion of the investigator, might impair the subject's tolerance of trial treatment.\n* Receipt of any organ transplantation including allogeneic stem-cell transplantation.\n\nExclusion Criteria Specific for parts:\n\nPart 2 and 3\n\n* No FFPE tumour sample available to conduct FGFR alteration eligibility tests and no biopsy option.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Patient or legal guardian, if permitted by local regulatory authorities, provides informed consent to participate in the study must be performed before any procedure's protocol related",
"criterions": [
{
"exact_snippets": "Patient or legal guardian ... provides informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Patient or legal guardian ... provides informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* age of ≥25 years old",
"criterions": [
{
"exact_snippets": "age of ≥25 years old",
"criterion": "age",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 25,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "age of ≥25 years old",
"criterion": "age",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 25,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Performance Score ≥70 in accordance with the Karnofsky Performance Score (KPS),",
"criterions": [
{
"exact_snippets": "Performance Score ≥70 ... Karnofsky Performance Score (KPS)",
"criterion": "Karnofsky Performance Score (KPS)",
"requirement": {
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "N/A"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Performance Score ≥70 ... Karnofsky Performance Score (KPS)",
"criterion": "Karnofsky Performance Score (KPS)",
"requirement": {
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "N/A"
}
}
}
]
}
},
{
"identified_line": {
"line": "* life expectancy period of at least 3 months on the screening day,",
"criterions": [
{
"exact_snippets": "life expectancy period of at least 3 months",
"criterion": "life expectancy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "life expectancy period of at least 3 months",
"criterion": "life expectancy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Have measurable disease according to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1)",
"criterions": [
{
"exact_snippets": "measurable disease according to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1)",
"criterion": "measurable disease",
"requirement": {
"requirement_type": "evaluation criteria",
"expected_value": "Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1)"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "measurable disease according to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1)",
"criterion": "measurable disease",
"requirement": {
"requirement_type": "evaluation criteria",
"expected_value": "Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1)"
}
}
]
}
},
{
"identified_line": {
"line": "* subject (or his/her partner) of childbearing potential willingness to use acceptable forms of contraception",
"criterions": [
{
"exact_snippets": "subject (or his/her partner) of childbearing potential",
"criterion": "childbearing potential",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "willingness to use acceptable forms of contraception",
"criterion": "willingness to use contraception",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "subject (or his/her partner) of childbearing potential",
"criterion": "childbearing potential",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "willingness to use acceptable forms of contraception",
"criterion": "willingness to use contraception",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* phosphate levels within normal range",
"criterions": [
{
"exact_snippets": "phosphate levels within normal range",
"criterion": "phosphate levels",
"requirement": {
"requirement_type": "range",
"expected_value": "within normal range"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "phosphate levels within normal range",
"criterion": "phosphate levels",
"requirement": {
"requirement_type": "range",
"expected_value": "within normal range"
}
}
]
}
},
{
"identified_line": {
"line": "* HIV, HCV (hepatitis C virus) and HBV negative (hepatitis B virus),",
"criterions": [
{
"exact_snippets": "HIV ... negative",
"criterion": "HIV status",
"requirement": {
"requirement_type": "status",
"expected_value": "negative"
}
},
{
"exact_snippets": "HCV (hepatitis C virus) ... negative",
"criterion": "HCV status",
"requirement": {
"requirement_type": "status",
"expected_value": "negative"
}
},
{
"exact_snippets": "HBV negative (hepatitis B virus)",
"criterion": "HBV status",
"requirement": {
"requirement_type": "status",
"expected_value": "negative"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "HIV ... negative",
"criterion": "HIV status",
"requirement": {
"requirement_type": "status",
"expected_value": "negative"
}
},
{
"exact_snippets": "HCV (hepatitis C virus) ... negative",
"criterion": "HCV status",
"requirement": {
"requirement_type": "status",
"expected_value": "negative"
}
},
{
"exact_snippets": "HBV negative (hepatitis B virus)",
"criterion": "HBV status",
"requirement": {
"requirement_type": "status",
"expected_value": "negative"
}
}
]
}
},
{
"identified_line": {
"line": "* adequate cardiac function",
"criterions": [
{
"exact_snippets": "adequate cardiac function",
"criterion": "cardiac function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "adequate cardiac function",
"criterion": "cardiac function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Part 1",
"criterions": [
{
"exact_snippets": "Part 1",
"criterion": "trial phase",
"requirement": {
"requirement_type": "phase",
"expected_value": "1"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Part 1",
"criterion": "trial phase",
"requirement": {
"requirement_type": "phase",
"expected_value": "1"
}
}
]
}
},
{
"identified_line": {
"line": "* Patients with histologically confirmed advanced gastric cancer, bladder cancer, squamous lung cancer or non-small cell lung cancer with squamous immunophenotype, cholangiocarcinoma, sarcoma or endometrial cancer, be refractory to prior therapies and without effective further treatment options.",
"criterions": [
{
"exact_snippets": "histologically confirmed advanced gastric cancer",
"criterion": "gastric cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed advanced gastric cancer",
"criterion": "gastric cancer",
"requirement": {
"requirement_type": "stage",
"expected_value": "advanced"
}
},
{
"exact_snippets": "histologically confirmed ... bladder cancer",
"criterion": "bladder cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... squamous lung cancer",
"criterion": "squamous lung cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... non-small cell lung cancer with squamous immunophenotype",
"criterion": "non-small cell lung cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... non-small cell lung cancer with squamous immunophenotype",
"criterion": "non-small cell lung cancer",
"requirement": {
"requirement_type": "immunophenotype",
"expected_value": "squamous"
}
},
{
"exact_snippets": "histologically confirmed ... cholangiocarcinoma",
"criterion": "cholangiocarcinoma",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... sarcoma",
"criterion": "sarcoma",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... endometrial cancer",
"criterion": "endometrial cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "refractory to prior therapies",
"criterion": "refractory to prior therapies",
"requirement": {
"requirement_type": "status",
"expected_value": true
}
},
{
"exact_snippets": "without effective further treatment options",
"criterion": "effective further treatment options",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "histologically confirmed advanced gastric cancer",
"criterion": "gastric cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed advanced gastric cancer",
"criterion": "gastric cancer",
"requirement": {
"requirement_type": "stage",
"expected_value": "advanced"
}
}
]
},
{
"exact_snippets": "histologically confirmed ... bladder cancer",
"criterion": "bladder cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... squamous lung cancer",
"criterion": "squamous lung cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"and_criteria": [
{
"exact_snippets": "histologically confirmed ... non-small cell lung cancer with squamous immunophenotype",
"criterion": "non-small cell lung cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... non-small cell lung cancer with squamous immunophenotype",
"criterion": "non-small cell lung cancer",
"requirement": {
"requirement_type": "immunophenotype",
"expected_value": "squamous"
}
}
]
},
{
"exact_snippets": "histologically confirmed ... cholangiocarcinoma",
"criterion": "cholangiocarcinoma",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... sarcoma",
"criterion": "sarcoma",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... endometrial cancer",
"criterion": "endometrial cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
}
]
},
{
"exact_snippets": "refractory to prior therapies",
"criterion": "refractory to prior therapies",
"requirement": {
"requirement_type": "status",
"expected_value": true
}
},
{
"exact_snippets": "without effective further treatment options",
"criterion": "effective further treatment options",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* Patients with histologically confirmed advanced gastric cancer, bladder cancer, squamous lung cancer or non-small cell lung cancer with squamous immunophenotype, be refractory to prior therapies and without effective further treatment options.",
"criterions": [
{
"exact_snippets": "histologically confirmed advanced gastric cancer",
"criterion": "gastric cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed advanced gastric cancer",
"criterion": "gastric cancer",
"requirement": {
"requirement_type": "stage",
"expected_value": "advanced"
}
},
{
"exact_snippets": "histologically confirmed ... bladder cancer",
"criterion": "bladder cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... squamous lung cancer",
"criterion": "squamous lung cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... non-small cell lung cancer with squamous immunophenotype",
"criterion": "non-small cell lung cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... non-small cell lung cancer with squamous immunophenotype",
"criterion": "non-small cell lung cancer",
"requirement": {
"requirement_type": "immunophenotype",
"expected_value": "squamous"
}
},
{
"exact_snippets": "refractory to prior therapies",
"criterion": "refractory to prior therapies",
"requirement": {
"requirement_type": "status",
"expected_value": true
}
},
{
"exact_snippets": "without effective further treatment options",
"criterion": "effective further treatment options",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "histologically confirmed advanced gastric cancer",
"criterion": "gastric cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed advanced gastric cancer",
"criterion": "gastric cancer",
"requirement": {
"requirement_type": "stage",
"expected_value": "advanced"
}
}
]
},
{
"exact_snippets": "refractory to prior therapies",
"criterion": "refractory to prior therapies",
"requirement": {
"requirement_type": "status",
"expected_value": true
}
},
{
"exact_snippets": "without effective further treatment options",
"criterion": "effective further treatment options",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "histologically confirmed ... bladder cancer",
"criterion": "bladder cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "refractory to prior therapies",
"criterion": "refractory to prior therapies",
"requirement": {
"requirement_type": "status",
"expected_value": true
}
},
{
"exact_snippets": "without effective further treatment options",
"criterion": "effective further treatment options",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "histologically confirmed ... squamous lung cancer",
"criterion": "squamous lung cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "refractory to prior therapies",
"criterion": "refractory to prior therapies",
"requirement": {
"requirement_type": "status",
"expected_value": true
}
},
{
"exact_snippets": "without effective further treatment options",
"criterion": "effective further treatment options",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
},
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "histologically confirmed ... non-small cell lung cancer with squamous immunophenotype",
"criterion": "non-small cell lung cancer",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "histologically confirmed ... non-small cell lung cancer with squamous immunophenotype",
"criterion": "non-small cell lung cancer",
"requirement": {
"requirement_type": "immunophenotype",
"expected_value": "squamous"
}
}
]
},
{
"exact_snippets": "refractory to prior therapies",
"criterion": "refractory to prior therapies",
"requirement": {
"requirement_type": "status",
"expected_value": true
}
},
{
"exact_snippets": "without effective further treatment options",
"criterion": "effective further treatment options",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 25 Years",
"criterions": [
{
"exact_snippets": "minimum age of 25 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 25,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 25 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 25,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* adequate blood, liver, renal and urine parameters",
"criterions": [
{
"exact_snippets": "adequate blood",
"criterion": "blood parameters",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate liver",
"criterion": "liver parameters",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate renal",
"criterion": "renal parameters",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate ... urine parameters",
"criterion": "urine parameters",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "adequate blood",
"criterion": "blood parameters",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate liver",
"criterion": "liver parameters",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate renal",
"criterion": "renal parameters",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate ... urine parameters",
"criterion": "urine parameters",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Inclusion Criteria Specific for parts:",
"criterions": []
},
"logical_structure": {
"and_criteria": []
}
},
{
"identified_line": {
"line": "Part 2 and 3",
"criterions": [
{
"exact_snippets": "Part 2",
"criterion": "trial part",
"requirement": {
"requirement_type": "participation",
"expected_value": "Part 2"
}
},
{
"exact_snippets": "Part 3",
"criterion": "trial part",
"requirement": {
"requirement_type": "participation",
"expected_value": "Part 3"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Part 2",
"criterion": "trial part",
"requirement": {
"requirement_type": "participation",
"expected_value": "Part 2"
}
},
{
"exact_snippets": "Part 3",
"criterion": "trial part",
"requirement": {
"requirement_type": "participation",
"expected_value": "Part 3"
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Any other current malignancy or malignancy diagnosed within the past five (5) years.",
"criterions": [
{
"exact_snippets": "Any other current malignancy",
"criterion": "current malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "malignancy diagnosed within the past five (5) years",
"criterion": "malignancy diagnosis",
"requirement": {
"requirement_type": "time since diagnosis",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Any other current malignancy",
"criterion": "current malignancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "malignancy diagnosed within the past five (5) years",
"criterion": "malignancy diagnosis",
"requirement": {
"requirement_type": "time since diagnosis",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Active brain metastases or leptomeningeal metastases.",
"criterions": [
{
"exact_snippets": "Active brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "leptomeningeal metastases",
"criterion": "leptomeningeal metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Active brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "leptomeningeal metastases",
"criterion": "leptomeningeal metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* concurrent anticancer treatment within 28 days before the start of trial treatment; major surgery within 28 days before the start of trial treatment); use of blood transfusion within 7 days before the start of trial treatment,",
"criterions": [
{
"exact_snippets": "concurrent anticancer treatment within 28 days before the start of trial treatment",
"criterion": "concurrent anticancer treatment",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
},
{
"exact_snippets": "major surgery within 28 days before the start of trial treatment",
"criterion": "major surgery",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
},
{
"exact_snippets": "use of blood transfusion within 7 days before the start of trial treatment",
"criterion": "use of blood transfusion",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 7,
"unit": "days"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "concurrent anticancer treatment within 28 days before the start of trial treatment",
"criterion": "concurrent anticancer treatment",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
},
{
"exact_snippets": "major surgery within 28 days before the start of trial treatment",
"criterion": "major surgery",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
},
{
"exact_snippets": "use of blood transfusion within 7 days before the start of trial treatment",
"criterion": "use of blood transfusion",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 7,
"unit": "days"
}
}
}
]
}
},
{
"identified_line": {
"line": "* prior therapy with an agent directed to another FGFR inhibitor,",
"criterions": [
{
"exact_snippets": "prior therapy with an agent directed to another FGFR inhibitor",
"criterion": "prior therapy with FGFR inhibitor",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "prior therapy with an agent directed to another FGFR inhibitor",
"criterion": "prior therapy with FGFR inhibitor",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* pregnancy and/or breastfeeding,",
"criterions": [
{
"exact_snippets": "pregnancy",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "breastfeeding",
"criterion": "breastfeeding",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "pregnancy",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "breastfeeding",
"criterion": "breastfeeding",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* phosphate levels above the upper limit of normal,",
"criterions": [
{
"exact_snippets": "phosphate levels above the upper limit of normal",
"criterion": "phosphate levels",
"requirement": {
"requirement_type": "comparison",
"expected_value": "> upper limit of normal"
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "phosphate levels above the upper limit of normal",
"criterion": "phosphate levels",
"requirement": {
"requirement_type": "comparison",
"expected_value": "> upper limit of normal"
}
}
}
},
{
"identified_line": {
"line": "* ectopic calcification/mineralization,",
"criterions": [
{
"exact_snippets": "ectopic calcification/mineralization",
"criterion": "ectopic calcification/mineralization",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ectopic calcification/mineralization",
"criterion": "ectopic calcification/mineralization",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* endocrine alteration related to calcium/phosphate homeostasis e.g. parathyroid disorders, history of parathyroidectomy,",
"criterions": [
{
"exact_snippets": "endocrine alteration related to calcium/phosphate homeostasis",
"criterion": "endocrine alteration",
"requirement": {
"requirement_type": "related to",
"expected_value": "calcium/phosphate homeostasis"
}
},
{
"exact_snippets": "parathyroid disorders",
"criterion": "parathyroid disorders",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "history of parathyroidectomy",
"criterion": "parathyroidectomy",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "endocrine alteration related to calcium/phosphate homeostasis",
"criterion": "endocrine alteration",
"requirement": {
"requirement_type": "related to",
"expected_value": "calcium/phosphate homeostasis"
}
},
{
"exact_snippets": "parathyroid disorders",
"criterion": "parathyroid disorders",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"exact_snippets": "history of parathyroidectomy",
"criterion": "parathyroidectomy",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* concomitant therapies increasing calcium/phosphate serum levels,",
"criterions": [
{
"exact_snippets": "concomitant therapies increasing calcium/phosphate serum levels",
"criterion": "concomitant therapies",
"requirement": {
"requirement_type": "effect on calcium/phosphate serum levels",
"expected_value": "increasing"
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "concomitant therapies increasing calcium/phosphate serum levels",
"criterion": "concomitant therapies",
"requirement": {
"requirement_type": "effect on calcium/phosphate serum levels",
"expected_value": "increasing"
}
}
}
},
{
"identified_line": {
"line": "* inability to take oral medicines,",
"criterions": [
{
"exact_snippets": "inability to take oral medicines",
"criterion": "ability to take oral medicines",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "inability to take oral medicines",
"criterion": "ability to take oral medicines",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* corneal disorder and/or keratopathy,",
"criterions": [
{
"exact_snippets": "corneal disorder",
"criterion": "corneal disorder",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "keratopathy",
"criterion": "keratopathy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "corneal disorder",
"criterion": "corneal disorder",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "keratopathy",
"criterion": "keratopathy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"exact_snippets": "corneal disorder",
"criterion": "corneal disorder",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "keratopathy",
"criterion": "keratopathy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* persisting toxicity related to prior therapy Grade > 1 CTCAE v5.0, except polyneuropathy and alopecia,",
"criterions": [
{
"exact_snippets": "persisting toxicity related to prior therapy Grade > 1 CTCAE v5.0",
"criterion": "persisting toxicity related to prior therapy",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "CTCAE v5.0"
}
}
},
{
"exact_snippets": "except polyneuropathy",
"criterion": "polyneuropathy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "except ... alopecia",
"criterion": "alopecia",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"not_criteria": {
"and_criteria": [
{
"exact_snippets": "persisting toxicity related to prior therapy Grade > 1 CTCAE v5.0",
"criterion": "persisting toxicity related to prior therapy",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "CTCAE v5.0"
}
}
},
{
"not_criteria": {
"exact_snippets": "except polyneuropathy",
"criterion": "polyneuropathy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
},
{
"not_criteria": {
"exact_snippets": "except ... alopecia",
"criterion": "alopecia",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* clinically significant (i.e., active) cardiovascular disease. History of abdominal fistula, bowel obstruction (Grade IV), gastrointestinal perforation, intra-abdominal abscess within 6 months of enrollment. Other significant diseases, which, in the opinion of the investigator, might impair the subject's tolerance of trial treatment.",
"criterions": [
{
"exact_snippets": "clinically significant (i.e., active) cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "clinically significant (i.e., active) cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "significance",
"expected_value": "clinically significant"
}
},
{
"exact_snippets": "History of abdominal fistula",
"criterion": "abdominal fistula",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of ... bowel obstruction (Grade IV)",
"criterion": "bowel obstruction",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of ... bowel obstruction (Grade IV)",
"criterion": "bowel obstruction",
"requirement": {
"requirement_type": "grade",
"expected_value": "IV"
}
},
{
"exact_snippets": "History of ... gastrointestinal perforation",
"criterion": "gastrointestinal perforation",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of ... intra-abdominal abscess within 6 months of enrollment",
"criterion": "intra-abdominal abscess",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of ... intra-abdominal abscess within 6 months of enrollment",
"criterion": "intra-abdominal abscess",
"requirement": {
"requirement_type": "timeframe",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
},
{
"exact_snippets": "Other significant diseases, which, in the opinion of the investigator, might impair the subject's tolerance of trial treatment",
"criterion": "other significant diseases",
"requirement": {
"requirement_type": "investigator's opinion",
"expected_value": "might impair tolerance of trial treatment"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "clinically significant (i.e., active) cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "clinically significant (i.e., active) cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "significance",
"expected_value": "clinically significant"
}
}
]
},
{
"exact_snippets": "History of abdominal fistula",
"criterion": "abdominal fistula",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "History of ... bowel obstruction (Grade IV)",
"criterion": "bowel obstruction",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of ... bowel obstruction (Grade IV)",
"criterion": "bowel obstruction",
"requirement": {
"requirement_type": "grade",
"expected_value": "IV"
}
}
]
},
{
"exact_snippets": "History of ... gastrointestinal perforation",
"criterion": "gastrointestinal perforation",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "History of ... intra-abdominal abscess within 6 months of enrollment",
"criterion": "intra-abdominal abscess",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of ... intra-abdominal abscess within 6 months of enrollment",
"criterion": "intra-abdominal abscess",
"requirement": {
"requirement_type": "timeframe",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
}
]
},
{
"exact_snippets": "Other significant diseases, which, in the opinion of the investigator, might impair the subject's tolerance of trial treatment",
"criterion": "other significant diseases",
"requirement": {
"requirement_type": "investigator's opinion",
"expected_value": "might impair tolerance of trial treatment"
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Receipt of any organ transplantation including allogeneic stem-cell transplantation.",
"criterions": [
{
"exact_snippets": "Receipt of any organ transplantation",
"criterion": "organ transplantation",
"requirement": {
"requirement_type": "receipt",
"expected_value": true
}
},
{
"exact_snippets": "including allogeneic stem-cell transplantation",
"criterion": "allogeneic stem-cell transplantation",
"requirement": {
"requirement_type": "receipt",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Receipt of any organ transplantation",
"criterion": "organ transplantation",
"requirement": {
"requirement_type": "receipt",
"expected_value": true
}
},
{
"exact_snippets": "including allogeneic stem-cell transplantation",
"criterion": "allogeneic stem-cell transplantation",
"requirement": {
"requirement_type": "receipt",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* No FFPE tumour sample available to conduct FGFR alteration eligibility tests and no biopsy option.",
"criterions": [
{
"exact_snippets": "No FFPE tumour sample available",
"criterion": "FFPE tumour sample",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
},
{
"exact_snippets": "no biopsy option",
"criterion": "biopsy option",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "No FFPE tumour sample available",
"criterion": "FFPE tumour sample",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
},
{
"exact_snippets": "no biopsy option",
"criterion": "biopsy option",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "Exclusion Criteria Specific for parts:",
"criterions": []
},
"logical_structure": {
"and_criteria": []
}
},
{
"identified_line": {
"line": "Part 2 and 3",
"criterions": [
{
"exact_snippets": "Part 2",
"criterion": "trial phase",
"requirement": {
"requirement_type": "phase",
"expected_value": "2"
}
},
{
"exact_snippets": "Part 3",
"criterion": "trial phase",
"requirement": {
"requirement_type": "phase",
"expected_value": "3"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Part 2",
"criterion": "trial phase",
"requirement": {
"requirement_type": "phase",
"expected_value": "2"
}
},
{
"exact_snippets": "Part 3",
"criterion": "trial phase",
"requirement": {
"requirement_type": "phase",
"expected_value": "3"
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"identified_line": {
"line": "* Subject's archival formalin-fixed paraffin-embedded (FFPE) tumour sample available for molecular alteration diagnostics, and/or a possibility to collect a new biopsy.",
"criterions": [
{
"exact_snippets": "archival formalin-fixed paraffin-embedded (FFPE) tumour sample available",
"criterion": "archival FFPE tumour sample",
"requirement": {
"requirement_type": "availability",
"expected_value": true
}
},
{
"exact_snippets": "possibility to collect a new biopsy",
"criterion": "new biopsy",
"requirement": {
"requirement_type": "possibility",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Present molecular alteration within FGFR 1, 2 or 3",
"criterions": [
{
"exact_snippets": "molecular alteration within FGFR 1, 2 or 3",
"criterion": "FGFR 1, 2 or 3 molecular alteration",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}